Search research articles
Contact Us
Filters
Showing results (121-130 of 142) with videos related to
Page
of 15
Sort By:
Psychopharmacology
|
December 13, 2019
4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels
Arvie Abiero, Chrislean Jun Botanas, Raly James Custodio, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 19, 2019
Topological analysis of the gp41 MPER on lipid bilayers relevant to the metastable HIV-1 envelope prefusion state
Yi Wang, Pavanjeet Kaur, Zhen-Yu J Sun, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 10, 2022
Effects of food and race on the pharmacokinetics of lazertinib in healthy subjects and patients with EGFR mutation-positive advanced non-small cell lung cancer
Ki Young Huh, Yeji Lim, Deok Yong Yoon, et al.
Molecular Neurobiology
|
June 10, 2025
Unraveling Predominantly Inattentive ADHD (ADHD-PI): Insights from Proteomic Analysis of the Striatum of Thyroid Hormone-Responsive Protein (THRSP)-Overexpressing Mice
Raly James Perez Custodio, Leandro Val Sayson, Ara Cho, et al.
Nature Structural & Molecular Biology
|
October 18, 2011
Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization
Mikyung Kim, Zhen-Yu J Sun, Kasper D Rand, et al.
Diabetes, Obesity & Metabolism
|
September 14, 2016
Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study)
Soo Lim, Kyung Ah Han, JaeMyung Yu, et al.
Addiction Biology
|
November 22, 2019
25B-NBOMe, a novel N-2-methoxybenzyl-phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: Evidence of abuse potential
Raly James Perez Custodio, Leandro Val Sayson, Chrislean Jun Botanas, et al.
Psychopharmacology
|
March 21, 2019
The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT<sub>2</sub> receptors
Leandro Val Sayson, Chrislean Jun Botanas, Raly James Perez Custodio, et al.
Biomolecules & Therapeutics
|
February 8, 2017
The Abuse Potential of α-Piperidinopropiophenone (PIPP) and α-Piperidinopentiothiophenone (PIVT), Two New Synthetic Cathinones with Piperidine Ring Substituent
Chrislean Jun Botanas, Seong Shoon Yoon, June Bryan de la Peña, et al.
Pharmacology, Biochemistry, and Behavior
|
January 9, 2017
The abuse potential of two novel synthetic cathinones with modification on the alpha-carbon position, 2-cyclohexyl-2-(methylamino)-1-phenylethanone (MACHP) and 2-(methylamino)-1-phenyloctan-1-one (MAOP), and their effects on dopaminergic activity
Chrislean Jun Botanas, Seong Shoon Yoon, June Bryan de la Peña, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 142) with videos related to
Sort By:
Page
of 15
Psychopharmacology
|
December 13, 2019
4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels
Arvie Abiero, Chrislean Jun Botanas, Raly James Custodio, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 19, 2019
Topological analysis of the gp41 MPER on lipid bilayers relevant to the metastable HIV-1 envelope prefusion state
Yi Wang, Pavanjeet Kaur, Zhen-Yu J Sun, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 10, 2022
Effects of food and race on the pharmacokinetics of lazertinib in healthy subjects and patients with EGFR mutation-positive advanced non-small cell lung cancer
Ki Young Huh, Yeji Lim, Deok Yong Yoon, et al.
Molecular Neurobiology
|
June 10, 2025
Unraveling Predominantly Inattentive ADHD (ADHD-PI): Insights from Proteomic Analysis of the Striatum of Thyroid Hormone-Responsive Protein (THRSP)-Overexpressing Mice
Raly James Perez Custodio, Leandro Val Sayson, Ara Cho, et al.
Nature Structural & Molecular Biology
|
October 18, 2011
Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization
Mikyung Kim, Zhen-Yu J Sun, Kasper D Rand, et al.
Diabetes, Obesity & Metabolism
|
September 14, 2016
Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study)
Soo Lim, Kyung Ah Han, JaeMyung Yu, et al.
Addiction Biology
|
November 22, 2019
25B-NBOMe, a novel N-2-methoxybenzyl-phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: Evidence of abuse potential
Raly James Perez Custodio, Leandro Val Sayson, Chrislean Jun Botanas, et al.
Psychopharmacology
|
March 21, 2019
The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT<sub>2</sub> receptors
Leandro Val Sayson, Chrislean Jun Botanas, Raly James Perez Custodio, et al.
Biomolecules & Therapeutics
|
February 8, 2017
The Abuse Potential of α-Piperidinopropiophenone (PIPP) and α-Piperidinopentiothiophenone (PIVT), Two New Synthetic Cathinones with Piperidine Ring Substituent
Chrislean Jun Botanas, Seong Shoon Yoon, June Bryan de la Peña, et al.
Pharmacology, Biochemistry, and Behavior
|
January 9, 2017
The abuse potential of two novel synthetic cathinones with modification on the alpha-carbon position, 2-cyclohexyl-2-(methylamino)-1-phenylethanone (MACHP) and 2-(methylamino)-1-phenyloctan-1-one (MAOP), and their effects on dopaminergic activity
Chrislean Jun Botanas, Seong Shoon Yoon, June Bryan de la Peña, et al.
Page
of 15